NeoStem (NBS) sells 51% interest in Chinese generic pharma Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NeoStem (NBS) sells 51% interest in Chinese generic pharma

Public Reply Prvt Reply Mark as Last Read File

PreviousNext

From: Pistol Pete	7/15/2012 2:06:08 PM
	of 1

NBS has been on a nice run of late. I'm looking forward to it continuing. Adult stem cell therapies and research don't have the negative stigma that embryonic do.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

PreviousNext